Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Increased bone resorption and osteopenia are a part of the lymphoproliferative phenotype of mice with systemic over-expression of interleukin-7 gene driven by MHC class II promoter.

Salopek D, Grcević D, Katavić V, Kovacić N, Lukić IK, Marusić A.

Immunol Lett. 2008 Dec 22;121(2):134-9. doi: 10.1016/j.imlet.2008.10.002. Epub 2008 Nov 4.

PMID:
18992278
2.

Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity.

Ikeda F, Nishimura R, Matsubara T, Hata K, Reddy SV, Yoneda T.

J Immunol. 2006 Aug 15;177(4):2384-90.

3.

Administration of cyclooxygenase-2 inhibitor reduces joint inflammation but exacerbates osteopenia in IL-1 alpha transgenic mice due to GM-CSF overproduction.

Niki Y, Takaishi H, Takito J, Miyamoto T, Kosaki N, Matsumoto H, Toyama Y, Tada N.

J Immunol. 2007 Jul 1;179(1):639-46.

4.

The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells.

Boban I, Jacquin C, Prior K, Barisic-Dujmovic T, Maye P, Clark SH, Aguila HL.

Bone. 2006 Dec;39(6):1302-12. Epub 2006 Aug 30.

PMID:
16938497
5.

Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential.

Fisher AG, Burdet C, Bunce C, Merkenschlager M, Ceredig R.

Int Immunol. 1995 Mar;7(3):415-23.

PMID:
7794821
6.

Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system.

De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Longo M, Vivarelli M, Muratori F, Berni S, Ballanti P, Ferrari S, Teti A.

Arthritis Rheum. 2006 Nov;54(11):3551-63.

8.

Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.

Sheng MH, Wergedal JE, Mohan S, Amoui M, Baylink DJ, Lau KH.

PLoS One. 2012;7(4):e35280. doi: 10.1371/journal.pone.0035280. Epub 2012 Apr 20.

9.

Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts.

Kawamata A, Inoue A, Miyajima D, Hemmi H, Mashima R, Hayata T, Ezura Y, Amagasa T, Yamanashi Y, Noda M.

J Cell Physiol. 2011 Dec;226(12):3087-93. doi: 10.1002/jcp.22909.

PMID:
21732353
10.

Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors.

Horowitz MC, Xi Y, Pflugh DL, Hesslein DG, Schatz DG, Lorenzo JA, Bothwell AL.

J Immunol. 2004 Dec 1;173(11):6583-91.

11.

Targeted transgenic expression of an osteoclastic transmembrane protein-tyrosine phosphatase in cells of osteoclastic lineage increases bone resorption and bone loss in male young adult mice.

Sheng MH, Amoui M, Stiffel V, Srivastava AK, Wergedal JE, Lau KH.

J Biol Chem. 2009 Apr 24;284(17):11531-45. doi: 10.1074/jbc.M808324200. Epub 2009 Feb 25.

12.

Periarticular osteopenia in adjuvant induced arthritis: role of interleukin-1 in decreased osteogenic and increased resorptive potential of bone marrow cells.

Suzuki Y, Tanihara M, Ichikawa Y, Osanai A, Nakagawa M, Ide M, Mizushima Y.

Ann Rheum Dis. 1995 Jun;54(6):484-90.

13.

Regulation of class II MHC gene expression by the inducible anti-sense RNA in transgenic mice.

Imoto S, Miki N, Hatano M, Aizawa S, Tokuhisa T.

Anal Biochem. 1993 May 1;210(2):231-4.

PMID:
8512058
14.

Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.

Schiltz C, Prouillet C, Marty C, Merciris D, Collet C, de Vernejoul MC, Geoffroy V.

J Cell Physiol. 2010 Jan;222(1):219-29. doi: 10.1002/jcp.21941.

PMID:
19780057
15.

Dissociation between bone resorption and bone formation in osteopenic transgenic mice.

Corral DA, Amling M, Priemel M, Loyer E, Fuchs S, Ducy P, Baron R, Karsenty G.

Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13835-40.

16.

Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S.

Cell. 2007 Sep 7;130(5):811-23.

17.

IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass.

Adamopoulos IE, Tessmer M, Chao CC, Adda S, Gorman D, Petro M, Chou CC, Pierce RH, Yao W, Lane NE, Laface D, Bowman EP.

J Immunol. 2011 Jul 15;187(2):951-9. doi: 10.4049/jimmunol.1003986. Epub 2011 Jun 13.

18.

Autoimmunity and bone.

Schwarz EM, Looney RJ, Drissi MH, O'Keefe RJ, Boyce BF, Xing L, Ritchlin CT.

Ann N Y Acad Sci. 2006 Apr;1068:275-83.

PMID:
16831928
19.

Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.

Weitzmann MN, Roggia C, Toraldo G, Weitzmann L, Pacifici R.

J Clin Invest. 2002 Dec;110(11):1643-50.

20.

The alpha-isoform of p38 MAPK specifically regulates arthritic bone loss.

Böhm C, Hayer S, Kilian A, Zaiss MM, Finger S, Hess A, Engelke K, Kollias G, Krönke G, Zwerina J, Schett G, David JP.

J Immunol. 2009 Nov 1;183(9):5938-47. doi: 10.4049/jimmunol.0901026. Epub 2009 Oct 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk